TreeFrog Therapeutics

TreeFrog Therapeutics is a startup founded in 2018 based in France. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 3 investors associated with the company.

TreeFrog Therapeutics develops a proprietary C‑Stem® 3D scalable manufacturing platform for induced pluripotent stem cell (iPSC) therapies to reduce production costs and support cell therapy clinical development and market access. The company partners with other cell therapy players to secure cell production and quality through its end-to-end manufacturing solution.